States have often been an incubator for innovative ideas in health technology pricing and reimbursement. In another example of necessity being the mother of invention, Medicaid expansion coupled with rising drug costs have forced state Medicaid authorities to seek new payment mechanisms that would contain drug costs. In June of this year, the Centers for Medicare and Medicaid Services (CMS) gave the green light to Oklahoma to pursue a Medicaid drug pricing initiative.